Innoviva (INVA) Inventory Average (2013 - 2026)
Innoviva's (INVA) quarterly Inventory Average came in at $39.0 million in Q1 2026, up 3.74% YoY from $37.6 million in Q1 2025, and up 0.62% on a QoQ basis from $38.8 million in Q4 2025.
Innoviva (INVA) Inventory Average (2013 - 2026) Analysis & Trends
Innoviva (INVA) has 7 years of Inventory Average data on file, last reported at $39.0 million in Q1 2026.
- Quarterly Inventory Average rose 3.74% year-over-year to $39.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.0 million (up 3.74% YoY) and the FY2025 annual result came in at $38.8 million, up 14.09% from the prior year.
- Inventory Average climbed to $39.0 million in Q1 2026, from $38.8 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $63.4 million in Q4 2022 to a low of $34.0 million in Q4 2024.
- A 5-year average of $42.8 million and a median of $39.9 million in 2023 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average slumped 35.87% — and 2025, when it increased 23.21%.
- Tracing INVA's Inventory Average over 5 years: stood at $63.4 million in 2022, then tumbled by 35.87% to $40.6 million in 2023, then declined by 16.36% to $34.0 million in 2024, then gained by 14.09% to $38.8 million in 2025, then gained by 0.62% to $39.0 million in 2026.
- The last three Inventory Average figures came in at $39.0 million (Q1 2026), $38.8 million (Q4 2025), and $43.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | 38.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.91 Mn |
| Mar 31, 2026 | 39.01 Mn |
| Dec 31, 2025 | 38.77 Mn |
| Sep 30, 2025 | 43.68 Mn |
| Jun 30, 2025 | 45.24 Mn |
| Mar 31, 2025 | 37.60 Mn |
| Dec 31, 2024 | 33.98 Mn |
| Sep 30, 2024 | 35.45 Mn |
| Jun 30, 2024 | 37.05 Mn |
| Mar 31, 2024 | 39.09 Mn |
| Dec 31, 2023 | 40.63 Mn |
| Sep 30, 2023 | 43.68 Mn |
| Jun 30, 2023 | 48.25 Mn |
| Mar 31, 2023 | 52.78 Mn |
| Dec 31, 2022 | 63.35 Mn |
| Mar 31, 2014 | 10.71 Mn |
| Dec 31, 2013 | 9.72 Mn |
| Sep 30, 2013 | 8.64 Mn |